Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly—A Subgroup Analysis of Routine Clinical Practice Data
Table 1
Baseline characteristics of the trial populations.
Patients aged >65 years
Patients aged ≤65 years
n
n
Gender
752
282
Male
206 (27.4%)
130 (46.1%)
Female
546 (72.6%)
152 (53.9%)
Age (years)
752
77.7 ± 6.5
282
56.2 ± 6.7
Body mass index (kg/m2)
744
29.5 ± 5.3
280
30.5 ± 6.7
Type of osteoarthritis
752
282
Kneea
577 (76.7%)
204 (72.3%)
Hipb
476 (63.3%)
149 (52.8%)
Knee and hip
301 (40%)
71 (25.2%)
Duration of pain
751
282
<1 month
8 (1.1%)
0
1–3 months
33 (4.4%)
16 (5.7%)
>3–6 months
52 (6.9%)
31 (11%)
>0.5–1 year
95 (12.7%)
32 (11.4%)
>1–2 years
112 (14.9%)
46 (16.3%)
>2 years
451 (60.1%)
157 (55.7%)
Type of pain
728
267
Pure nociceptive pain
54 (7.4%)
15 (5.6%)
Pure neuropathic pain
13 (1.8%)
3 (1.1%)
Mixed pain
661 (90.8%)
249 (93.3%)
Data are mean ± SD or number of patients (%); aall patients with knee osteoarthritis and knee/hip osteoarthritis; ball patients with hip osteoarthritis and hip/knee osteoarthritis.
